COPD Trial, Recruiting NCT07222410 Sponsor: Fisher and Paykel Healthcare Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT07222410
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are mentally able to understand and agree to take part in the trial yourself
  • You are 22 years of age or older
  • You are currently in hospital with low oxygen levels or difficulty breathing
  • You have been diagnosed with COPD (a lung condition that makes it hard to breathe)
  • Your doctor has decided you are suitable for, or you are already receiving, high-flow oxygen through your nose at a rate of at least 25 litres per minute
  • You are expected to need this oxygen and high-flow therapy for more than 24 hours in total (this does not have to be all at once)

Who may not be able to join:

  • You are currently using, or your doctors have decided you need, a breathing support mask that helps push air into your lungs (called non-invasive ventilation)
  • Your blood pressure is dangerously low or you need special medicines to keep your heart and blood pressure stable
  • You are receiving end-of-life care
  • You have a condition affecting your nose or face that would prevent you from using the high-flow nasal oxygen equipment
  • You are pregnant or breastfeeding
  • You have a condition affecting your thinking or level of consciousness that means you cannot give consent yourself
  • You are not able to wear a standard sticky pulse oximeter sensor on your finger (confirm with trial site)
  • Your doctor feels that taking part in the trial would not be safe for you for any other reason
  • You have another serious health condition that your doctor believes could significantly affect your health over the next 30 days
  • You have already taken part in this clinical trial before

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 64 9 574 0123

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fisher and Paykel Healthcare
Registry
ClinicalTrials.gov
Start date
7 January 2026
Est. completion
1 November 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Percentage of time with SpO2 in target range over period of observation; Percentage of time with SpO2 out of target range over period of observation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov